Clinical Trial Update: A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD [Phase 3]

View source ↗

Summary

A Phase 3 long-term safety trial of nebulized SUN-101 in chronic obstructive pulmonary disease has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• SUN-101 (glycopyrrolate)

Snippet

Sponsor: Sunovion Respiratory Development Inc. | Conditions: Chronic Obstructive Pulmonary Disease (COPD) | Phase 3 | Status: COMPLETED | Results posted: 2018-03-13